Working tirelessly behind every licence & would-be licences ! See our in-licensing #priorities: #HIV; #HCV; #HBV; #TB; #infant #RSV #prevention; #malaria; #PPR; #CF; #cancer; #diabetes; #cardiovascular; #metabolics lnkd.in/eSFfWKbR ! ⭐ #Equity #AccessToMedicines #BetterMeds4Kids #GlobalHealth

#RSV causes 100,000 child deaths yearly — almost entirely in LMICs. On #WPD, MPP calls for urgent action to make prevention tools like #nirsevimab and #clesrovimab widely accessible, esp. in LMICs. Voluntary licensing can help close the gap. Learn more: medicinespatentpool.org/story-post/p...

On #WorldDiabetesDay, we stand with @who.int’s call: #diabetes affects every life stage. Two inspiring women share their journeys through #pregnancy with #Type1diabetes— highlighting urgent needs for affordable #insulin, tech access, and #education. No one should be left behind. 🔗 bit.ly/3WYVNzB

🦠 #RSV kills 100,000+ young children yearly, 97% in LMICs. Prevention works, but access to life-saving monoclonal antibodies is limited. On #WorldChildrensDay, let’s push for affordable RSV prevention so every child gets a healthy start. Learn more: bit.ly/4o0XGqo

MPP provides sustainable solutions that save millions of lives in the short and long run. 🌍 MPP punches well above its weight. 💪 Would you like to explore ways in which we could collaborate? 🤝 Get in touch: medicinespatentpool.org/licensingsav... #Sustainability #FundingHealthEquity

MPP’s work in #licensing, #techtransfer and capacity-building aligns with Article 12’s benefit-sharing goals. We’ve long partnered with @who.int and Member States to turn these principles into access. 🤝🌍 👉 medicinespatentpool.org/news-publica...

🌍 Around the world, millions of people cannot access the medicines they need — not because the treatments don’t exist, but because they remain out of reach. At MPP, we work to change that. ✨ Join us: lnkd.in/eDizXjQb Watch the video: www.youtube.com/watch?v=3kqd... #LicensingSavesLives

MPP joins @who.int @unaids.org @unitaid.bsky.social & partners to mark #WorldAIDSDay. Expanding access to dolutegravir-based regimens, paediatric formulations & long-acting therapeutics is vital for equity & choice. Through licensing, MPP helps make this possible. 🔗 shorturl.at/gEMKd

MPP and @unitaid.bsky.social are co-hosting “Breaking New Grounds: Long-Acting HIV Treatment for a New Generation”, at #ICASA2025. 📅 Wednesday 3 December 2025 | 11:45–12:30 GMT 📍 Room Prof. Souleymane Mboup & online Join us to discuss why long-acting HIV treatment matters. lnkd.in/e7DTMEYc

Yesterday, @who.int released its first-ever guideline on the use of GLP-1 therapies for adults living with obesity. This milestone follows the inclusion of GLP-1 medicines in the Essential Medicines List for managing type 2 diabetes in high-risk groups. 👉 www.who.int/news/item/01...

On #WorldAIDSDay, let's remember the role of #communities in driving the response, and how #access to optimal #HIV care - for everyone living with HIV - supports #solidarity and #dignity in the broader journey towards #progress 🤍

On #WorldAIDSDay, let's remember how #access to optimal #HIV care - for everyone living with HIV - supports #solidarity and #dignity in the broader journey towards #progress 🤍

On #WorldChildrensDay, MPP proudly stands as a founding member of GAP-f, driving global collaboration to ensure children everywhere have access to lifesaving medicines. Learn more: www.who.int/initiatives/... @pablorojo.bsky.social @sebmoringva.bsky.social

It was a pleasure to take part in GAP-f annual members' meeting, reviewing the tremendous #progress of our collaborative network in prioritizing #BetterMeds4Kids in 5 new therapeutic areas during 2025! -> This is what #WorldChildrensDay is about! #SickleCellDisease #Epilepsy #RSV #Dengue #Malaria

Today is #WorldChildrensDay - It is a time to reflect and ask ourselves if we have continued to #prioritize #children this last year. While we never exclude children outright, we often forget to #adapt our #efforts to their #needs. Let's changed that & develop #BetterMeds4Kids! 🤍

Among 100,000 #RSV deaths/year in children, 97% are in #LMICs & half in infants <6 months. Today is #WorldChildrensDay & we are reminded about inequitable diseases disproportionately affecting our young loved ones. Let's work together & create real change! 🤍 #Equity #GlobalHealth #BetterMeds4Kids

This #FixedDoseCombination (combining 3 drugs in 1 tablet: #pALD) allows children to benefit from #innovation as adults have enjoyed for many years. This #equity supports #adherence and better #health outcomes for our loved young ones. 🤍 - #BetterMeds4Kids #WorldChildrensDay #ChildrenLivingWithHIV

As countries are transitioning to the best first-line regimen for #children living with #HIV, we are happy to share that for the first time in Q1 and Q2 of 2025, orders for paediatric ALD have surpassed the orders of paediatric DTG regimen. 👶 Together, we continue to advance paediatric HIV care! 🤝

Continued and diversified funding is essential for MPP to expand its mandate and future projects. Your contribution can make a significant impact. Would you like to explore ways in which we could collaborate? 👉 medicinespatentpool.org/licensingsav... #FundingHealthEquity #GlobalHealth

With 🇹🇳 #AORTIC2025 now wrapped up, we want to thank everyone who joined our #MythBuster game at the Medicines Patent Pool booth! #Oncology professionals, researchers, policymakers, and advocates shared powerful insights about the realities of #cancercare in LMICs. #AccessToMedicines #HealthEquity

The Global Accelerator for Paediatric Formulations (GAP-f) at @who.int & @accesstomedicinefoundation.org invite pharmaceutical innovators & manufacturers to discuss the GAP-f 2025-30 strategy & discuss medicines for childhood cancer, epilepsy, malaria, RSV -> Register at who.zoom.us/meeting/regi...

Around 375 patients with #chronicmyeloidleukaemia (CML) in El Salvador, Indonesia & the Philippines are now accessing quality-assured generic #nilotinib. Made possible through a #voluntarylicence from @novartis.bsky.social to MPP via the ATOM coalition - @uiccofficial.bsky.social! lnkd.in/eruiP-Gv

Last week, our India and Geneva teams came together for the annual all-staff retreat, a great moment to reflect and plan ahead.☀️ We explored MPP’s future strategy, priorities and ongoing #LicensingSavesLives campaign. Thank you to all colleagues for your energy, we look forward to what lies ahead!

At the UN High-Level Meeting on NCDs and Mental Health, MPP and partners convened a roundtable on expanding access to NCD medicines in LMICs. Together, we aim to turn commitments into action for equitable, affordable access. 🌍 medicinespatentpool.org/news-publica...

MPP and the Vizuri Health Dynamics Foundation are partnering to strengthen #local pharmaceutical #manufacturing and improve access to essential medicines in LMICs. 👉 medicinespatentpool.org/story-post/m...

🌍 We’re hiring! The Medicines Patent Pool is looking for a Programme Finance Officer to join our team in Geneva, Switzerland. 📅 Apply by: 31 October 2025 📧 Send your application to: [email protected] Learn more 👉 medicinespatentpool.org/call-for-app...

Meaningful days in Accra for #AHMTEC2025! MPP’s Tiwadayo Braimoh and Meghmala Das joined a panel on #licensing opportunities for African manufacturing, showcasing how the MPP model supports access to essential health products and builds sustainable manufacturing capacity across #Africa.

💊 The price of generic TLD (tenofovir, lamivudine, dolutegravir), the WHO-recommended HIV treatment, now costs under $37 per person per year, this has been a game changer in low- and middle-income countries.🌏 🤝 How we can collaborate together: medicinespatentpool.org/licensingsav...

🌍 MPP at #CPHIA2025 MPP is pleased to participate in this year’s #CPHIA2025, joining partners to discuss sustainable #localmanufacturing and equitable access to medical products across Africa. @eburrone.bsky.social - @tiwabraimoh.bsky.social

Children are too often left out of clinical trials. In Nature, our Head of HIV Justine Odionyi calls for drug development on neglected diseases to include children from the start. Read the piece (EN/FR): @nature.com #BeatNTDs #GlobalHealth www.nature.com/articles/d44...

Voluntary #LicensingSavesLives by making medicines and health technologies affordable for low- and middle-income countries. 🌍 🤝 But we cannot achieve this great change without your help! 👉 medicinespatentpool.org/licensingsav...

Very #proud of being part of the amazing @medicinespatentpool.org #team! Together, we make a positive difference for #GlobalHealth!

Ensuring #equity in #access is how we can transform #innovation into positive #health outcomes. Have a look at the short film below and read the latest article from colleagues on "Expanding access to long-acting #HIV therapy in low-income and middle-income countries" 💙 lnkd.in/eTd3TMDM #GlobalHealth

An #timely & #symbolic #milestone for long-acting #HIV #prevention and #treatment ! A privilege to be at #IAS2025 to share positive news with #partners of community, civil society, academia, governments, international organizations, industry... -- #GlobalHealth #AccessToMedicines #Equity #Solidarity

Unitaid applauds ViiV Healthcare and the @medicinespatentpool.org for advancing equitable access to HIV treatment. Strong partnerships like this help deliver life-changing innovations to the communities that need them most. Learn more: medicinespatentpool.org/news-publica...

“We don’t have to explain ourselves all over again.” In Kigali, we visited HDI, led by Dr. Aflodis Kagaba, where sex workers, LGBTQ+ people & people who use drugs find stigma-free care, every day. ✍️ Read the full story: medicinespatentpool.org/story-post/b...

🚨 We’re hiring! ⚖️ Associate Counsel 💉 Consultant: Feasibility & Concept Design Expert 👉 Check out our career page for more information: medicinespatentpool.org/who-we-are/c... #GlobalHealth #AccessToMedicines #mRNA #Vaccines #Hiring

“Recommitting to global solidarity: introducing the #KigaliCalltoAction” via @thelancet.com #IAS2025

I just found this old postcard from a few years back... It remains true and could have been printed yesterday... 😢 --- #ChildHealth #PaediatricHIV #BetterMeds4Kids

The recently-launched #GAPf strategy for 2025-2030 will include a focus on developing and rolling out #BetterMeds4Kids to address the increasing threat of #dengue... www.who.int/publications...

How is HIV science around the world navigating US funding cuts? Follow us as we bring you exclusive coverage from the 13th IAS Conference on HIV science in Kigali, Rwanda. #IAS2025 #HIVScience

USAID has officially closed. Congress passed the President's domestic policy agenda, robbing about 17 million Americans access to health care in favor of tax cuts for the rich. The US Supreme Court preserved preventative care, including PrEP. Read all about it, and more: avac.org/blog/global-...

Looking forward to reconnecting at #IAS2025 and achieving #health #impact! @medicinespatentpool.org @iasociety.bsky.social

Pushing the boundary, expanding #access to #health products. Lots achieved, but much more remains! Join our efforts to allow populations of low- and middle-income countries often most affected by diseases reap the benefits of modern #medical #science! This is what #equity looks like! #GlobalHealth

Congratulations to #Botswana for being "validated as the 1st high #HIV-burden country [...], and the 1st in #Africa, to reach @who.int’s Gold Tier status for eliminating vertical transmission of HIV as a public #health issue"! An AIDS-free generation is possible! www.afro.who.int/countries/bo...

Huge kudos to @iasociety.bsky.social for their impressive efforts to offer #language #interpretation - in over 60 languages - for key sessions at #IAS2025 ! Well done ! #inclusive #diverse #accessible #conference www.iasociety.org/conferences/...

Each year, RSV kills 50,000 #infants <6 months, mostly in #LMICs. @who.int recommends #prevention with an #antibody (2 products now approved by regulatory agencies) or a #vaccine. There is hope. Let's ensure infants benefit from life-saving #progress! #BetterMeds4Kids #ChildHealth

Because “ #health is always the first to suffer when #funding falls short ” -> #donate to @who.int and help protect everyone’s health! donate.who.foundation

Measles is dangerous Please vaccinate your children!!! www.cbc.ca/news/canada/...

Very interesting lessons from COVID and pragmatic approach linking #research and #development with #equitable #access outcomes in mind wellcomeopenresearch.org/articles/9-374